George Kulik - Publications


36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hassan MS, Pullikuth A, Nelson KC, Flores A, Karpova Y, Baiz D, Zhu S, Sui G, Huang Y, D'Agostino R, Hemal A, von Holzen U, Debinski W, Kulik G. Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Molecular Cancer Research : McR. PMID 32928910 DOI: 10.1158/1541-7786.MCR-19-1037  0.48
2018 Wright EW, Nelson RA, Karpova Y, Kulik G, Welker ME. Synthesis and PI3 Kinase Inhibition Activity of Some Novel Trisubstituted Morpholinopyrimidines. Molecules (Basel, Switzerland). 23. PMID 29996482 DOI: 10.3390/molecules23071675  1
2018 Nelson RA, Schronce T, Huang Y, Albugami A, Kulik G, Welker ME. Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines. Molecules (Basel, Switzerland). 23. PMID 29973512 DOI: 10.3390/molecules23071628  1
2016 Zhang Q, Wan M, Shi J, Horita DA, Miller LD, Kute TE, Kridel SJ, Kulik G, Sui G. Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation. Journal of Molecular Cell Biology. PMID 26762111 DOI: 10.1093/jmcb/mjw002  1
2015 Kulik G. Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network. Asian Journal of Andrology. 17: 471-4. PMID 25578933 DOI: 10.4103/1008-682X.143749  1
2014 Kulik G. Precision therapy to target apoptosis in prostate cancer. Experimental Oncology. 36: 226-30. PMID 25537214  1
2014 Hassan S, Karpova Y, Flores A, D'Agostino R, Danhauer SC, Hemal A, Kulik G. A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies. International Urology and Nephrology. 46: 505-10. PMID 24057680 DOI: 10.1007/s11255-013-0513-0  1
2013 Sun X, Bao J, Nelson KC, Li KC, Kulik G, Zhou X. Systems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapy. Plos Computational Biology. 9: e1003358. PMID 24339759 DOI: 10.1371/journal.pcbi.1003358  1
2013 Hassan S, Karpova Y, Flores A, D'Agostino R, Kulik G. Surgical stress delays prostate involution in mice. Plos One. 8: e78175. PMID 24223137 DOI: 10.1371/journal.pone.0078175  1
2013 Baiz D, Hassan S, Choi YA, Flores A, Karpova Y, Yancey D, Pullikuth A, Sui G, Sadelain M, Debinski W, Kulik G. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer. Neoplasia (New York, N.Y.). 15: 1172-83. PMID 24204196 DOI: 10.1593/neo.13986  1
2013 Yancey D, Nelson KC, Baiz D, Hassan S, Flores A, Pullikuth A, Karpova Y, Axanova L, Moore V, Sui G, Kulik G. BAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells. Plos One. 8: e74561. PMID 24040284 DOI: 10.1371/journal.pone.0074561  1
2013 Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer. The American Journal of Pathology. 183: 1339-50. PMID 23938323 DOI: 10.1016/j.ajpath.2013.06.027  1
2013 Boyacioglu O, Stuart CH, Kulik G, Gmeiner WH. Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages. Molecular Therapy. Nucleic Acids. 2: e107. PMID 23860551 DOI: 10.1038/mtna.2013.37  1
2013 Welker ME, Kulik G. Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. Bioorganic & Medicinal Chemistry. 21: 4063-91. PMID 23735831 DOI: 10.1016/j.bmc.2013.04.083  1
2013 Kulik G. Targeting psychoemotional stress to treat prostate cancer. Asian Journal of Andrology. 15: 362-3. PMID 23584381 DOI: 10.1038/aja.2013.30  1
2013 Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D'Agostino R, Danial N, Datta SR, Kulik G. Behavioral stress accelerates prostate cancer development in mice. The Journal of Clinical Investigation. 123: 874-86. PMID 23348742 DOI: 10.1172/JCI63324  1
2012 Baiz D, Pinder TA, Hassan S, Karpova Y, Salsbury F, Welker ME, Kulik G. Synthesis and characterization of a novel prostate cancer-targeted phosphatidylinositol-3-kinase inhibitor prodrug. Journal of Medicinal Chemistry. 55: 8038-46. PMID 22924393 DOI: 10.1021/jm300881a  1
2009 Smith AJ, Karpova Y, D'Agostino R, Willingham M, Kulik G. Expression of the Bcl-2 protein BAD promotes prostate cancer growth. Plos One. 4: e6224. PMID 19593445 DOI: 10.1371/journal.pone.0006224  1
2007 Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. The Journal of Clinical Investigation. 117: 1866-75. PMID 17607361 DOI: 10.1172/JCI31494  1
2007 Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, Carson JP, Weber MJ, Register TC, Chen YQ, Penn RB, Kulik G. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. The Journal of Biological Chemistry. 282: 14094-100. PMID 17353197 DOI: 10.1074/jbc.M611370200  1
2006 Sastry KS, Karpova Y, Kulik G. Epidermal growth factor protects prostate cancer cells from apoptosis by inducing BAD phosphorylation via redundant signaling pathways. The Journal of Biological Chemistry. 281: 27367-77. PMID 16847055 DOI: 10.1074/jbc.M511485200  1
2006 Sastry KS, Smith AJ, Karpova Y, Datta SR, Kulik G. Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. The Journal of Biological Chemistry. 281: 20891-901. PMID 16728406 DOI: 10.1074/jbc.M602928200  1
2002 Carson JP, Behnam M, Sutton JN, Du C, Wang X, Hunt DF, Weber MJ, Kulik G. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Research. 62: 18-23. PMID 11782351  1
2001 Kulik G, Carson JP, Vomastek T, Overman K, Gooch BD, Srinivasula S, Alnemri E, Nunez G, Weber MJ. Tumor necrosis factor alpha induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells. Cancer Research. 61: 2713-9. PMID 11289152  1
1999 Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B. Cancer Research. 59: 1449-53. PMID 10197612  1
1998 Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Molecular and Cellular Biology. 18: 6711-8. PMID 9774684  1
1997 Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular and Cellular Biology. 17: 1595-606. PMID 9032287  1
1997 Kulik G, Klippel A, Weber M. The role of akt in survival signalling of igf-i Faseb Journal. 11: A1165.  1
1996 Peterson JE, Kulik G, Jelinek T, Reuter CW, Shannon JA, Weber MJ. Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites. Requirement for transformation by src. The Journal of Biological Chemistry. 271: 31562-71. PMID 8940173 DOI: 10.1074/jbc.271.49.31562  1
1996 Kulik G, Peterson JE, Weber MJ. Tyrosine kinase acttvity of the igf-1 keceptor is required for igf-1 mediated protection from uvinduced apoptosis Faseb Journal. 10: A1090.  1
1992 Ivashchenko IuD, Kulik GA, Fil'chenkov AA. [Dependence of epidermal growth factor activation on its affinity and oligomerization]. Biulleten' Eksperimental'Noĭ Biologii I Meditsiny. 113: 84-7. PMID 1391875  1
1992 Ivashchenko YD, Kulik GA, Fil'chenkov AA. Dependence of activation of the epidermal growth factor receptor on its affinity and oligomerization Bulletin of Experimental Biology and Medicine. 113: 123-126. DOI: 10.1007/BF00787765  1
1992 Filchenkov AA, Slukvin II, Pogrebnoi PV, Kudryavets Yu. I, Didkovskaya LP, Kulik GA, Chernyshev VP, Bykorez AI. Application of flow cytometry with anti-EGF-receptor antibody and 125I-EGF binding assay for detection of EGF-receptors in certain human tumor cell lines Eksperimentalnaya Onkologiya. 14: 45-49.  1
1991 Kulik GA, Ivashchenko IuD, Kononenko LI, Fil'chenkov AA, Bykorez AI. [The effect of epidermal growth factor on protein phosphorylation in normal and transformed hepatocytes]. Ukrainskiĭ Biokhimicheskiĭ Zhurnal (1978). 63: 16-22. PMID 1882457  1
1990 Ivashchenko IuD, Garmanchuk LV, Fil'chenkov AA, Kulik GA, Kononenko LI, Bykorez AI. [Changes in the contents of epidermal growth factor and EGF-like polypeptides in the liver tissue of rats in N-nitrosodiethylamine-induced hepatocarcinogenesis]. EksperimentalʹNai͡a Onkologii͡A. 12: 31-3. PMID 2261874  1
1989 Ivashchenko IuD, Gut IT, Garmanchuk LV, Kulik GA, Vykorez AI. [Change in the number of epidermal growth factor receptors of hepatocytes during liver regeneration in rats]. Tsitologiia. 31: 453-9. PMID 2787940  1
Show low-probability matches.